{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:45:35Z","timestamp":1740185135678,"version":"3.37.3"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government","award":["NRF-2019R1G1A1099644"],"award-info":[{"award-number":["NRF-2019R1G1A1099644"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Cancers are promoted by abnormal alterations in biological processes, such as cell cycle and apoptosis. An immediate reason for those aberrant processes is the deregulation of their involved transcription factors (TFs). Thus, the deregulated TFs in cancer have been experimented as successful therapeutic targets, such as RARA and RUNX1. This therapeutic strategy can be accelerated by characterizing new potential TF targets.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Two kinds of therapeutic signatures of TFs in A375 (skin) and HT29 (colon) cancer cells were characterized by analyzing TF activities under effective and ineffective compounds to cancer. First, the therapeutic TFs (TTs) were identified as the TFs that are significantly activated or repressed under effective compared to ineffective compounds. Second, the therapeutically correlated TF pairs (TCPs) were determined as the TF pairs whose activity correlations show substantial discrepancy between the effective and ineffective compounds. It was facilitated by incorporating (i)compound-induced gene expressions (LINCS), (ii) compound-induced cell viabilities (GDSC) and (iii) TF\u2013target interactions (TRUST2). As a result, among 627 TFs, the 35 TTs (such as MYCN and TP53) and the 214 TCPs (such as FOXO3 and POU2F2 pair) were identified. The TTs and the proteins on the paths between TCPs were compared with the known therapeutic targets, tumor suppressors, oncogenes and CRISPR-Cas9 knockout screening, which yielded significant consequences. We expect that the results provide good candidates for therapeutic TF targets in cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and implementation<\/jats:title>\n                  <jats:p>The data and Python implementations are available at https:\/\/github.com\/jmjung83\/TT_and_TCP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Supplementary information<\/jats:title>\n                  <jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btaa765","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:13:35Z","timestamp":1598440415000},"page":"1008-1014","source":"Crossref","is-referenced-by-count":0,"title":["Characterizing therapeutic signatures of transcription factors in cancer by incorporating profiles in compound treated cells"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-8347","authenticated-orcid":false,"given":"Jinmyung","family":"Jung","sequence":"first","affiliation":[{"name":"Division of Data Science, College of Information and Communication Technology, The University of Suwon , Hwaseong 18323, Republic of Korea"}]}],"member":"286","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"2023051612170186900_btaa765-B1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.3593","article-title":"Functional characterization of somatic mutations in cancer using network-based inference of protein activity","volume":"48","author":"Alvarez","year":"2016","journal-title":"Nat. Genet"},{"key":"2023051612170186900_btaa765-B2","doi-asserted-by":"crossref","first-page":"295.","DOI":"10.3389\/fonc.2014.00295","article-title":"The evolution of prostate cancer therapy: targeting the androgen receptor","volume":"4","author":"Aragon-Ching","year":"2014","journal-title":"Front. Oncol"},{"key":"2023051612170186900_btaa765-B3","doi-asserted-by":"crossref","first-page":"39048","DOI":"10.18632\/oncotarget.16587","article-title":"CBX7 negatively regulates migration and invasion in glioma via Wnt\/\u03b2-catenin pathway inactivation","volume":"8","author":"Bao","year":"2017","journal-title":"Oncotarget"},{"key":"2023051612170186900_btaa765-B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejcb.2013.10.001","article-title":"POU transcription factors in melanocytes and melanoma","volume":"93","author":"Besch","year":"2014","journal-title":"Eur. J. Cell Biol"},{"key":"2023051612170186900_btaa765-B5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trecan.2015.07.001","article-title":"Targeting transcription factors in cancer","volume":"1","author":"Bhagwat","year":"2015","journal-title":"Trends Cancer"},{"key":"2023051612170186900_btaa765-B6","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/onc.2010.616","article-title":"Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer","volume":"30","author":"Booy","year":"2011","journal-title":"Oncogene"},{"key":"2023051612170186900_btaa765-B7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ccr.2009.12.050","article-title":"A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo","volume":"17","author":"Cerchietti","year":"2010","journal-title":"Cancer Cell"},{"key":"2023051612170186900_btaa765-B8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2011.53","article-title":"Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma","volume":"25","author":"Chng","year":"2011","journal-title":"Leukemia"},{"key":"2023051612170186900_btaa765-B9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcp.1115","article-title":"Homeobox genes in normal and malignant cells","volume":"188","author":"Cillo","year":"2001","journal-title":"J. Cell. Physiol"},{"key":"2023051612170186900_btaa765-B10","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/nar\/gky092","article-title":"UniProt: the universal protein knowledgebase","volume":"46","author":"Consortium","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023051612170186900_btaa765-B11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrc906","article-title":"Transcription factors as targets for cancer therapy","volume":"2","author":"Darnell","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"2023051612170186900_btaa765-B12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00018-015-2112-y","article-title":"FOXO transcription factors in cancer development and therapy","volume":"73","author":"De Brach\u00e8ne","year":"2016","journal-title":"Cell. Mol. Life Sci"},{"key":"2023051612170186900_btaa765-B13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol"},{"key":"2023051612170186900_btaa765-B14","doi-asserted-by":"crossref","first-page":"2331.","DOI":"10.3748\/wjg.v19.i15.2331","article-title":"Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer","volume":"19","author":"Fang","year":"2013","journal-title":"World J. Gastroenterol. WJG"},{"key":"2023051612170186900_btaa765-B15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/978-1-4612-4380-9_6","volume-title":"Breakthroughs in Statistics","author":"Fisher","year":"1992"},{"key":"2023051612170186900_btaa765-B16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1158\/0008-5472.CAN-17-1679","article-title":"Transcription factor activities enhance markers of drug sensitivity in cancer","volume":"78","author":"Garcia-Alonso","year":"2018","journal-title":"Cancer Res"},{"key":"2023051612170186900_btaa765-B17","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023051612170186900_btaa765-B18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.aaa0314","article-title":"A small-molecule inhibitor of the aberrant transcription factor CBF\u03b2-SMMHC delays leukemia in mice","volume":"347","author":"Illendula","year":"2015","journal-title":"Science"},{"key":"2023051612170186900_btaa765-B19","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/jcmm.13470","article-title":"Identification of Sox6 as a regulator of pancreatic cancer development","volume":"22","author":"Jiang","year":"2018","journal-title":"J. Cell. Mol. Med"},{"key":"2023051612170186900_btaa765-B20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/bioinformatics\/bty774","article-title":"Deconvoluting essential gene signatures for cancer growth from genomic expression in compound-treated cells","volume":"35","author":"Jung","year":"2019","journal-title":"Bioinformatics"},{"key":"2023051612170186900_btaa765-B21","doi-asserted-by":"crossref","first-page":"W212","DOI":"10.1093\/nar\/gkz446","article-title":"ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"Keenan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2023051612170186900_btaa765-B22","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3892\/or.2016.5086","article-title":"RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer","volume":"36","author":"Kim","year":"2016","journal-title":"Oncol. Rep"},{"key":"2023051612170186900_btaa765-B23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1755-148X.2010.00697.x","article-title":"Genome-wide analysis of POU3F2\/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene","volume":"23","author":"Kobi","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"2023051612170186900_btaa765-B24","doi-asserted-by":"crossref","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023051612170186900_btaa765-B25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-13-38","article-title":"Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma","volume":"13","author":"Luan","year":"2014","journal-title":"Mol. Cancer"},{"key":"2023051612170186900_btaa765-B26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12885-017-3226-4","article-title":"Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer","volume":"17","author":"McInnes","year":"2017","journal-title":"BMC Cancer"},{"key":"2023051612170186900_btaa765-B27","first-page":"22","article-title":"Utility of LHRH antagonists for advanced prostate cancer","volume":"21","author":"Moul","year":"2014","journal-title":"Can. J. Urol"},{"key":"2023051612170186900_btaa765-B28","doi-asserted-by":"crossref","first-page":"D529","DOI":"10.1093\/nar\/gky1079","article-title":"The BioGRID interaction database: 2019 update","volume":"47","author":"Oughtred","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2023051612170186900_btaa765-B29","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.ejca.2010.05.011","article-title":"The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients","volume":"46","author":"Pallante","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"2023051612170186900_btaa765-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-65077-y","article-title":"SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HnScc)","volume":"10","author":"Panchal","year":"2020","journal-title":"Sci. Rep"},{"key":"2023051612170186900_btaa765-B31","doi-asserted-by":"crossref","first-page":"baq020","DOI":"10.1093\/database\/baq020","article-title":"GeneCards Version 3: the human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database"},{"key":"2023051612170186900_btaa765-B32","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1038\/sj.onc.1204551","article-title":"Homeobox gene Cdx1 regulates Ras, Rho and PI3 kinase pathways leading to transformation and tumorigenesis of intestinal epithelial cells","volume":"20","author":"Soubeyran","year":"2001","journal-title":"Oncogene"},{"key":"2023051612170186900_btaa765-B33","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L 1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2023051612170186900_btaa765-B34","doi-asserted-by":"crossref","first-page":"155798831881690","DOI":"10.1177\/1557988318816907","article-title":"KLF2 inhibits the migration and invasion of prostate cancer cells by downregulating MMP2","volume":"13","author":"Wang","year":"2019","journal-title":"Am. J. Men's Health"},{"key":"2023051612170186900_btaa765-B35","first-page":"2114","article-title":"Comprehensive analysis of microRNA\/mRNA signature in colon adenocarcinoma","volume":"21","author":"Wang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci"},{"key":"2023051612170186900_btaa765-B36","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"2023051612170186900_btaa765-B37","first-page":"28","article-title":"The generalization ofstudent's' problem when several different population variances are involved","volume":"34","author":"Welch","year":"1947","journal-title":"Biometrika"},{"key":"2023051612170186900_btaa765-B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0661-3","article-title":"Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis"},{"key":"2023051612170186900_btaa765-B39","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2023051612170186900_btaa765-B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-01951-6","article-title":"Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics","volume":"7","author":"Yoshimaru","year":"2017","journal-title":"Sci. Rep"},{"key":"2023051612170186900_btaa765-B41","first-page":"77","article-title":"Inhibition of SATB1 by shRNA suppresses the proliferation of cutaneous malignant melanoma","volume":"29","author":"Zhang","year":"2014","journal-title":"Cancer Biother. Radiopharm"},{"key":"2023051612170186900_btaa765-B42","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cbin.10824","article-title":"Runx3 inhibits melanoma cell migration through regulation of cell shape change","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell Biol. Int"},{"key":"2023051612170186900_btaa765-B43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fphys.2018.00535","article-title":"Prognostic and clinicopathological significance of SATB1 in colorectal cancer: a meta-analysis","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Physiol"},{"key":"2023051612170186900_btaa765-B44","doi-asserted-by":"crossref","first-page":"D1023","DOI":"10.1093\/nar\/gkv1268","article-title":"TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes","volume":"44","author":"Zhao","year":"2016","journal-title":"Nucleic Acids Res"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btaa765\/35052362\/btaa765.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/37\/7\/1008\/50341157\/btaa765.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/37\/7\/1008\/50341157\/btaa765.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T12:18:43Z","timestamp":1684239523000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/37\/7\/1008\/5901539"}},"subtitle":[],"editor":[{"given":"Jonathan","family":"Wren","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,5,17]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btaa765","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"type":"print","value":"1367-4803"},{"type":"electronic","value":"1367-4811"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,9,4]]}}}